Lars Hendrik Müschen

Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients

Stefan Gingele, Thais Langer Jacobus, Franz Felix Konen et al. · Cells · 2018 · 133 citations · Full text

Clinical Immunology, Cell Therapy, T-regulatory Cell +19

Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson’s Disease Patients

Martin Klietz, A. Tulke, Lars Hendrik Müschen et al. · Frontiers in Neurology · 2018 · 63 citations · Full text

Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers’ Lives

Pavel Schischlevskij, Isabell Cordts, René Günther et al. · Brain Sciences · 2021 · 59 citations · Full text

Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy

Alma Osmanovic, Gresa Ranxha, Mareike Kumpe et al. · Journal of Neurology · 2020 · 52 citations · Full text

Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany

E Schönfelder, Alma Osmanovic, Lars Hendrik Müschen et al. · Orphanet Journal of Rare Diseases · 2020 · 36 citations · Full text